Severe eosinophilia as a manifestation of acute graft-versus-host disease

Oncology. 2008;75(3-4):134-6. doi: 10.1159/000155224. Epub 2008 Sep 15.

Abstract

Significant peripheral eosinophilia in association with acute graft-versus-host disease (GVHD) is rare. Here we report a case of eosinophilia in a 30-year-old woman with relapsed acute myelogenous leukemia after an allogeneic bone marrow transplant who was treated with donor lymphocyte infusion (DLI). A month after the DLI, she developed a pruritic erythematous rash, hepatic enzyme elevations and eosinophilia that peaked at 23,300 cells/mm(3). A diagnosis of acute GVHD was made and the patient was treated with corticosteroids with a resolution of all of the aforementioned findings. The authors suggest that eosinophilia in a bone marrow transplantation patient should raise suspicion of GVHD.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Bone Marrow Transplantation
  • Eosinophilia / diagnosis*
  • Eosinophilia / drug therapy
  • Female
  • Glucocorticoids / therapeutic use
  • Graft vs Host Disease / diagnosis*
  • Graft vs Host Disease / drug therapy
  • Graft vs Leukemia Effect
  • Humans
  • Leukemia, Myeloid, Acute / pathology
  • Leukemia, Myeloid, Acute / therapy*
  • Lymphocyte Transfusion
  • Neoplasm Recurrence, Local / diagnosis
  • Salvage Therapy

Substances

  • Glucocorticoids